Volver al
artículo.
Referencias para el artículo
- Foster S. Herbs for Your Health. Loveland, CO: Interweave Press,
1996, 37–8.
- Tyler, VE. The Honest Herbal, 3d ed. Binghamton, NY: Pharmaceutical
Products Press, 1993, 119–21.
- Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in
Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
227–9.
- Institute of Medicine. Dietary Reference Intakes: a risk assessment model for
establishing upper intake levels for nutrients. Washington, DC: National Academy Press,
1998.
- Cantox Health Sciences International. Safety assessment and determination of a
tolerable upper limit for ephedra. December 19, 2000.
www.crnusa.org/CRNCantoxreportindex.html.
- Foster S. Herbs for Your Health. Loveland, CO: Interweave Press,
1996, 37–8.
- Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine
Communications, 1998, 125–6.
- White LM, Gardner SF, Gurley BJ, et al. Pharmacokinetics and cardiovascular
effects of ma-huang (Ephedra sinica) in normotensive adults. J Clin
Pharmacol 1997;37:116–21.
- Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine
Communications, 1998, 125–6.
- Powell T, Hsu FF, Turk J, Hruska K. Ma-huang strikes again: Ephedrine
nephrolithiasis. Am J Kidney Dis 1998;32:153–9.
- Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system
events associated with dietary supplements containing ephedra alkaloids. New Engl J
Med 2000;343:1833–8.
- Blumenthal M, Busse WR, Goldberg A, et al. (eds). The Complete Commission
E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Integrative Medicine
Communications, 1998, 125–6.
- Cantox Health Sciences International. Safety assessment and determination of a
tolerable upper limit for ephedra. December 19, 2000.
www.crnusa.org/CRNCantoxreportindex.html